Free Trial

Cigna Group $CI Stock Holdings Raised by RFG Advisory LLC

Cigna Group logo with Medical background

Key Points

  • RFG Advisory LLC increased its stake in Cigna Group by 151.3% during the 2nd quarter, now holding shares valued at approximately $590,000.
  • Analysts are optimistic about Cigna Group, with Barclays raising its price target from $354.00 to $383.00 and most ratings reflecting a "Moderate Buy" sentiment.
  • Cigna Group recently announced a quarterly dividend of $1.51, translating to an annualized yield of 2.0%, with a payout ratio of 32.97%.
  • Five stocks to consider instead of Cigna Group.

RFG Advisory LLC raised its stake in Cigna Group (NYSE:CI - Free Report) by 151.3% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 1,784 shares of the health services provider's stock after purchasing an additional 1,074 shares during the period. RFG Advisory LLC's holdings in Cigna Group were worth $590,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Flaharty Asset Management LLC acquired a new position in shares of Cigna Group in the 1st quarter valued at about $28,000. 1248 Management LLC bought a new stake in Cigna Group in the 1st quarter valued at about $29,000. Activest Wealth Management lifted its position in Cigna Group by 360.0% in the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider's stock valued at $30,000 after purchasing an additional 72 shares during the last quarter. Retirement Wealth Solutions LLC lifted its position in Cigna Group by 74.1% in the 2nd quarter. Retirement Wealth Solutions LLC now owns 101 shares of the health services provider's stock valued at $33,000 after purchasing an additional 43 shares during the last quarter. Finally, Saudi Central Bank bought a new stake in Cigna Group in the 1st quarter valued at about $36,000. Institutional investors own 86.99% of the company's stock.

Analyst Ratings Changes

Several analysts recently weighed in on the stock. Barclays lifted their price objective on shares of Cigna Group from $354.00 to $383.00 and gave the company an "overweight" rating in a research report on Thursday, September 4th. Truist Financial set a $375.00 price objective on shares of Cigna Group in a research report on Tuesday, September 2nd. The Goldman Sachs Group assumed coverage on shares of Cigna Group in a research report on Tuesday. They issued a "buy" rating and a $370.00 price objective on the stock. Weiss Ratings reiterated a "hold (c+)" rating on shares of Cigna Group in a research report on Wednesday, October 8th. Finally, Cantor Fitzgerald restated an "overweight" rating and set a $365.00 price target on shares of Cigna Group in a research report on Tuesday, August 26th. Two analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and three have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $369.89.

Read Our Latest Research Report on CI

Cigna Group Stock Up 3.0%

NYSE CI opened at $299.81 on Friday. The company has a debt-to-equity ratio of 0.65, a current ratio of 0.71 and a quick ratio of 0.71. The company's 50 day simple moving average is $297.27 and its 200 day simple moving average is $308.29. Cigna Group has a 12 month low of $256.89 and a 12 month high of $353.55. The company has a market capitalization of $80.03 billion, a P/E ratio of 16.37, a PEG ratio of 0.85 and a beta of 0.45.

Cigna Group (NYSE:CI - Get Free Report) last released its earnings results on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, topping analysts' consensus estimates of $7.15 by $0.05. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The business had revenue of $67.13 billion for the quarter, compared to the consensus estimate of $62.61 billion. During the same period in the previous year, the firm earned $6.72 EPS. The business's revenue for the quarter was up 11.0% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Equities research analysts expect that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 18th. Investors of record on Thursday, September 4th were issued a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.0%. The ex-dividend date was Thursday, September 4th. Cigna Group's payout ratio is presently 32.97%.

Insider Buying and Selling

In other news, insider Brian C. Evanko sold 5,368 shares of Cigna Group stock in a transaction that occurred on Friday, October 3rd. The shares were sold at an average price of $300.00, for a total value of $1,610,400.00. Following the transaction, the insider directly owned 51,182 shares of the company's stock, valued at $15,354,600. This trade represents a 9.49% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Nicole S. Jones sold 28,526 shares of Cigna Group stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the completion of the transaction, the insider directly owned 25,648 shares in the company, valued at approximately $7,694,400. This trade represents a 52.66% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.70% of the stock is owned by insiders.

About Cigna Group

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

See Also

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cigna Group Right Now?

Before you consider Cigna Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.

While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.